Avindra Nath

Credentials: · ·

History

Investigation and Treatment of Undiagnosed Neuroinflammatory Diseases
National Institute of Neurological Disorders and Stroke · U01
PI · $2.9M · University of California, San Francisco
2021–2026
Role of CNS Opportunistic Infections in Subsequent Development of HIV Encephaliti
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $672K · Johns Hopkins University
2008–2013
SSRI-Neuroprotection for HIV/Drug Abuse
National Institute on Drug Abuse · R01
Contact PI · $1.1M · Johns Hopkins University
2008–2013
A Novel CNS-Penetrable Antiretroviral
National Institute of Mental Health · R43
PI · $250K · Jericho Sciences, Llc
2010–2012

Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)
Principal investigator · Not yet recruiting · Phase 1
National Institute of Neurological Disorders and Stroke (NINDS)
2026–2028
Cross-Sectional Evaluation of Persistence of SARS-CoV-2 Remnants After Recovery From Acute Infection
Principal investigator · Recruiting
National Institute of Neurological Disorders and Stroke (NINDS)
2025–2027
Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2
Principal investigator · Enrolling by invitation · Phase 2
National Institute of Neurological Disorders and Stroke (NINDS)
2023–2026
An Observational Study of Neurologic Function After COVID-19 Infection
Principal investigator · Completed
National Institute of Neurological Disorders and Stroke (NINDS)
2020–2023